General InformationLife Biosciences is a Boston-based biotech company founded in 2018 with 51-200 employees focused on longevity and anti-aging therapies using AI-driven discovery and aging biology research
Funding & FinancialsThe company has raised approximately $50-75 million across multiple rounds including a Series B, backed by investors focused on longevity and precision medicine
Leadership & TeamFounded by a team of experienced biotech and longevity scientists; specific CEO name requires direct confirmation but leadership includes PhDs in molecular biology and aging research
Recent ActivityLife Biosciences has been advancing multiple longevity programs and partnering with academic institutions on aging biology research, with focus on translating fundamental longevity science into clinical applications